Safety and Efficacy Trial of BHV3000 (Rimegepant) 75 mg for the Acute Treatment of Migraine
Clinical trial NCT04574362 · COMPLETED
Trial details
- NCT number
- NCT04574362
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-22
- Primary completion
- 2021-11-24
- Enrollment
- 1648
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.